The philosophy of the IMP
since its establishment in 1995 has always been to support successful
research, but also its realization and transfer into successful business
products. Accordingly the foundation of spin-off companies involving IMP
researchers has been encouraged.
information on any of these companies click on their logo on the left.
PET Net GmbH
Am Wetterkreuz 21
91058 Erlangen, Germany
Positron Emission Tomography (PET) has often been announced as one of the important future imaging modalities and has recently even been hailed as the "imaging modality of the new millennium". The University of Erlangen-Nürnberg has included PET imaging in its long-term planning. However, the supply with the necessary positron-emitting radiopharmaceuticals was the big problem until the late 1990s.
An initiative of Prof. W. Kalender from 1995 to 1997 to obtain public funding for a cyclotron centre was highly acknowledged regarding its importance for Erlangen the Medical Valley and its goals, but did not result in the necessary grants. The efforts were finally successful when the IMP and private investors joined in a "public-private partnership" to establish a cyclotron centre in the form of PET Net GmbH.
PET Net's mission and interest is to provide radiopharmaceuticals to the region of northern Bavaria and beyond its borders. The university's interest is to have access to the infrastructure, i.e. a cyclotron and the hot labs, necessary to enable basic and applied clinical research in the field of PET. PET Net was founded in 1998 and started operations in 1999 with Prof. W. Kalender as its "Geschäftsführer" (CEO); this position shall ensure that research interests will be kept in mind. Production of HF-18 and FDG started in 2000. PET Net already provided positron emitters to the Clinic for Nuclear Medicine. The cooperation will hopefully increase in quality and extent as a new PET scanner will be installed in the Clinic for Nuclear Medicine in 2002 and as PET-CT research at the IMP and with its partners is increasing.